G

Genomed SA
WSE:GEN

Watchlist Manager
Genomed SA
WSE:GEN
Watchlist
Price: 24 PLN -16.08% Market Closed
Market Cap: 31.7m PLN

Wall Street
Price Targets

GEN Price Targets Summary
Genomed SA

There are no price targets for GEN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Genomed SA Competitors:
Price Targets
PRTA
Prothena Corporation PLC
114% Upside
ALKS
Alkermes Plc
58% Upside
4599
StemRIM Inc
180% Upside
IVVD
Invivyd Inc
166% Upside
GILD
Gilead Sciences Inc
9% Upside
ACAD
ACADIA Pharmaceuticals Inc
7% Upside
QTTB
Homology Medicines Inc
261% Upside
ABBV
Abbvie Inc
9% Upside

Revenue
Forecast

Revenue Estimate
Genomed SA

Revenue forecast
is not available for
Genomed SA

Operating Income
Forecast

Operating Income Estimate
Genomed SA

Operating Income forecast
is not available for
Genomed SA

Net Income
Forecast

Net Income Estimate
Genomed SA

Net Income forecast
is not available for
Genomed SA
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GEN's stock price target?
Not Available

GEN doesn't have any price targets made by Wall Street professionals.

Back to Top